Stock Screener App

Gratuito - Play StoreApp Store

Installare Installare

Dow:

Nasdaq:

S&P 500:

TXMD

$1.801.64%-0.03

Therapeuticsmd Inc (TXMD)

Date: O: H: L: C: Vol:

Therapeuticsmd Inc Borsa (TXMD) Ultime notizie

TherapeuticsMD, Inc. Estimates – NASDAQ:TXMD - TradingView

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

TherapeuticsMD Inc (NASDAQ: TXMD) Share Price, TXMD Stock News, TXMD Share Price & Updates - Kalkine

TherapeuticsMD (TXMD) Edges Higher to $1.97 as Shares Hold Above Key Support - Thematic ETF Flow - https://www.dars.gov.et/

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

TherapeuticsMD Inc (NASDAQ: TXMD) Share Price, TXMD Stock News, TXMD Share Price & Updates - kalkine.ca

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Therapeuticsmd Stock Price Forecast. Should You Buy TXMD? - StockInvest.us

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

TXMD Q3 2023 Earnings: EPS Misses by 154.9% as Revenue Remains at Zero - EBITDA Margin Trends - vinanet.vn

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

TherapeuticsMD (TXMD) Holds Steady at $2.22 as Traders Eye Tight Trading Range - Long Setup Ideas - vinanet.vn

TherapeuticsMD (TXMD) Holds Steady at $2.22 as Traders Eye Tight Trading Range - Combination Correction - dars.gov.et

TherapeuticsMD (TXMD) Holds Steady at $2.22 as Traders Eye Tight Trading Range - Cup and Handle - careplusvn.com

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

THERAPEUTICSMD STOCK : BIG PRICE RECOVERY | TXMD STOCK Moon (nkL8YZ0GKj) - Mshale

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

TherapeuticsMD (TXMD) Quarterly Figures: EPS Falls Short of Its Estimate under the Current Snapshot; Post-Earnings: The Stock Ends Up 0.49% in the Latest Reading - Analyst Drop Coverage - vinanet.vn

TherapeuticsMD (TXMD) Quarterly Figures: EPS Falls Short of Its Estimate under the Current Snapshot; Post-Earnings: The Stock Ends Up 0.49% in the Latest Reading - Pre-Announcement Alert - siam.in

TherapeuticsMD (TXMD) Quarterly Figures: EPS Falls Short of Its Estimate under the Current Snapshot; Post-Earnings: The Stock Ends Up 0.49% in the Latest Reading - Gross Profit Margin - dars.gov.et

TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available Record - High Volume Node - vinanet.vn

TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available Record - Key Reversal Day - vinanet.vn

TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available Record - Social Sentiment - careplusvn.com

Simile a TXMD

CPHI$0.62493.86%

BFRI$0.87296.29%